A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Fasting Condition)
Phase of Trial: Phase I
Latest Information Update: 20 May 2016
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux; Peptic ulcer
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 13 Sep 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 13 Sep 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2010 New trial record